Search Results - "Lee, Susie A"
-
1
Increased Lipogenesis, Induced by AKT-mTORC1-RPS6 Signaling, Promotes Development of Human Hepatocellular Carcinoma
Published in Gastroenterology (New York, N.Y. 1943) (01-03-2011)“…Background & Aims De novo lipogenesis is believed to be involved in oncogenesis. We investigated the role of aberrant lipid biosynthesis in the pathogenesis of…”
Get full text
Journal Article -
2
AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways
Published in Hepatology (Baltimore, Md.) (01-03-2012)“…Activation of v‐akt murine thymoma viral oncogene homolog (AKT) and Ras pathways is often implicated in carcinogenesis. However, the oncogenic cooperation…”
Get full text
Journal Article -
3
Synergistic role of sprouty2 inactivation and c‐Met up‐regulation in mouse and human hepatocarcinogenesis
Published in Hepatology (Baltimore, Md.) (01-08-2010)“…Sprouty2 (Spry2), a negative feedback regulator of the Ras/mitogen‐activated protein kinase (MAPK) pathway, is frequently down‐regulated in human…”
Get full text
Journal Article -
4
RNA interference as therapeutics for hepatocellular carcinoma
Published in Recent patents on anti-cancer drug discovery (01-01-2011)“…Hepatocellular carcinoma (HCC), a major form of primary liver cancer, is one of the leading causes of cancer related deaths worldwide. Hepatitis B and C…”
Get more information
Journal Article -
5
Inactivation of Spry2 accelerates AKT-driven hepatocarcinogenesis via activation of MAPK and PKM2 pathways
Published in Journal of hepatology (01-09-2012)“…Background & Aims Aberrant activation of the AKT oncogenic pathway and downregulation of the Sprouty 2 ( Spry2 ) tumor suppressor gene are frequently observed…”
Get full text
Journal Article -
6
Integration of genomic analysis and in vivo transfection to identify sprouty 2 as a candidate tumor suppressor in liver cancer
Published in Hepatology (Baltimore, Md.) (01-04-2008)“…Hepatocellular carcinoma (HCC) is 1 of the leading causes of cancer‐related deaths worldwide, yet the molecular genetics underlying this malignancy are still…”
Get full text
Journal Article -
7
The zebrafish forkhead transcription factor Foxi1 specifies epibranchial placode-derived sensory neurons
Published in Development (Cambridge) (01-06-2003)“…Vertebrate epibranchial placodes give rise to visceral sensory neurons that transmit vital information such as heart rate, blood pressure and visceral…”
Get full text
Journal Article -
8
Role of cyclin D1 as a mediator of c-Met- and beta-catenin-induced hepatocarcinogenesis
Published in Cancer research (Chicago, Ill.) (01-01-2009)“…Activation of c-Met signaling and beta-catenin mutations are frequent genetic events observed in liver cancer development. Recently, we demonstrated that…”
Get full text
Journal Article -
9
Synergistic role of Spry2 inactivation and c-Met upregulation in mouse and human hepatocarcinogenesis
Published in Hepatology (Baltimore, Md.) (01-08-2010)“…Sprouty2 (Spry2), a negative feedback regulator of the Ras/MAPK pathway, is frequently downregulated in human hepatocellular carcinoma (HCC). In the present…”
Get full text
Journal Article -
10
AKT and N-Ras co-activation in the mouse liver promotes rapid carcinogenesis via mTORC1, FOXM1/SKP2, and c-Myc pathways
Published in Hepatology (Baltimore, Md.) (19-12-2011)“…Activation of v-akt murine thymoma viral oncogene homolog (AKT) and Ras pathways is often implicated in carcinogenesis. However, the oncogenic cooperation…”
Get full text
Journal Article -
11
Role of Cyclin D1 as a Mediator of c-Met- and β-Catenin-lnduced Hepatocarcinogenesis
Published in Cancer research (Chicago, Ill.) (2009)Get full text
Journal Article